产品说明
一般描述
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
生化/生理作用
卡巴拉汀是一种口服口服、脑透过性、可逆的胆碱酯酶抑制剂，可增强阿尔茨海默症和帕金森氏病患者的认知功能。卡巴拉汀可同时抑制丁酰胆碱酯酶和乙酰胆碱酯酶。
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAB1259 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
基本信息
| 经验(实验)分子式 | C14H22N2O2 · C4H6O6 |
| 分子量 | 400.42 |
| NACRES | NA.24 |
产品性质
| 质量水平 | 300 |
| 等级 | certified reference material pharmaceutical secondary standard |
| 形式 | powder |
| CofA | current certificate can be downloaded |
| 包装 | pkg of 1 g |
| application(s) | pharmaceutical |
| 药典可追溯性 | traceable to PhEur Y0001516 traceable to USP 1604858 |
| 储存温度 | 2-8℃ |
| InChI | 1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m00/s1 |
| InChI key | GWHQHAUAXRMMOT-RWALOXMOSA-N |
安全信息
| 象形图 |   |
| 警示用语： | Danger |
| 危险声明 | H300 - H411 |
| 预防措施声明 | P264 - P270 - P273 - P301 + P310 - P391 - P405 |
| 危险分类 | Acute Tox. 2 Oral - Aquatic Chronic 2 |
| 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
